Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research
The antibody therapy is now being tested as a way to prevent acute respiratory distress in COVID-19 patients. An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus. The drug, a […]
Continue Reading